Testing a new asthma drug in healthy people and those with asthma
Part of Immune system & allergy, Lungs & breathing clinical trials.
This study tests an investigational drug called PRA-216, first in healthy volunteers to check safety, then in people with mild-to-moderate asthma to see if it helps control symptoms. It's an early-stage trial to find out if the drug is safe and works.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- You are generally healthy with no major medical issues.
- You are willing to attend all study visits and follow the rules.
- If you have asthma, you must have been diagnosed at least 1 year ago and currently take daily asthma medication.
- You cannot have smoked or used nicotine products in the last 3 months (or have a history of heavy smoking).
- You cannot have donated blood or plasma in the last 2 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing a new drug called PRA-216 for people with COPD to see if it is safe and how it affects certain markers in the body. It may be an option if you have stable COPD and are on regular medications.
This study tests a new injected medicine (RC1416) for people with moderate-to-severe asthma that is not well controlled with daily inhalers. It may help reduce asthma attacks and improve breathing.
This study tests different doses of a new medicine (PF-08103402) to see how well it is tolerated and how it works in both healthy adults and adults with mild to moderate asthma. It helps researchers find the right dose for future studies.
This study tests an experimental drug called 610 for people with severe asthma that is not well-controlled with standard medicines. The goal is to see if adding 610 can improve asthma control and reduce flare-ups.
This study tests an investigational drug to see if it can improve asthma control in people whose asthma is not well managed with current treatments. It may help reduce symptoms and improve lung function.
This study tests a new medicine called PF-07275315 for people with moderate-to-severe asthma that is not well controlled with their current inhalers. It is for adults who have had asthma for at least a year, have had recent flare-ups needing steroids, and are not taking other biologic treatments.
Hear when a new Mild to Moderate Asthma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.